New Parkinson's treatment aims to tame medication side effects
NCT ID NCT07151378
Summary
This study is testing if a therapy called Lecigon, delivered directly to the intestines, is better than standard oral medications at managing the neuropsychiatric side effects that can occur with Parkinson's disease treatment. It will involve 150 adults with Parkinson's who experience these specific medication-related symptoms. Researchers will compare Lecigon to the current best medical treatment over six months to see which one better controls symptoms like impulsivity, mood swings, and compulsive behaviors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Neurology, Department forNeurodegenerative Disease, and Hertie-Institute forClinical Brain Research
Tübingen, 72076, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.